November 30, 2015

Report from World Conference on Hair Research 2015

Follicum report from World Conference on Hair Research, November 18-21, 2015 in Miami, USA by CEO Jan Alenfall The 2015 WCHR Scientific meeting has the overall goal of presenting new research, sharing experiences, and discussing the advancement and knowledge of hair growth as well as skin-, hair- and scalp diseases. In addition it is a […]

October 26, 2015

French Swedish Life Science Day 2015

Follicum attended the  French Swedish Life  Science  Day 2015  on 20 October in Paris.  The company presented their research projects and had the opportunity to meet with investors and representatives from pharmaceutical companies. The purpose of the meetings was to initiate contacts for future capital investments and potential collaborations. There was significant interest in Follicum’s drug candidates.

October 1, 2015

Follicum’s patent preliminary approved

Follicum has received a preliminary approval – a so called “Intention to Grant” – by the European Patent Office (EPO) regarding the company’s patent application for stimulation of hair growth. To read the full press release (in Swedish) please click here. For more information about Follicum’s research results, please contact: Jan Alenfall, CEO Tel +46 (0)46 19 21 […]

September 9, 2015

Cooperation initiated with research group in Berlin for the planned clinical study

As previously communicated, Follicum’s intention is to start a clinical phase I/IIa study around year-end 2015/early 2016. We can now announce that a cooperation with the Clinical Research Center for Hair and Skin Science (“CRC”) in Berlin, Germany, has been initiated regarding our planned clinical phase I/IIa study. Follicum’s intention is to submit an application […]

September 1, 2015

Follicum has completed toxicity studies

Follicum announced in March 2015  that they had started two larger toxicity studies to  add information to the two short time toxicity studies and  continue development. The short time studies were finalized in February 2015, and showed no adverse effects. The two larger toxicity studies have now been finished according to plan, showing very promising […]

August 25, 2015

Drug substance ready for production

Follicum announce today that the synthesis of the peptide has been completed.  The peptide is the active ingredient of the product planned to be used in the clinical Phase I/IIa study. Production of product for the clinical Phase I/IIa study Follicum announced in early June that the company had signed an agreement with the peptide […]

August 21, 2015

Half-year Report 2015

Follicum’s half-year report 2015 (1 January to 30 June) is now published. Click here to open the report (in Swedish).

June 2, 2015

Cooperation agreement signed for clinical trials

Follicum announce today that a joint cooperation agreement has been signed with PolyPeptide Group and Recipharm AB in anticipation of the clinical trials which are estimated to start in the beginning of 2016. Read more here.

May 22, 2015

Financial Report Q1

Follicum’s financial report for the first quarter 2015 (1 January to 31 March) is now published. Click here to open the report (in Swedish).